Vaxcyte, Inc.
Key Metrics
Market Snapshot
About
Vaxcyte is a clinical-stage biotechnology company developing next-generation vaccines to prevent bacterial infectious diseases. The company focuses on pneumococcal, Group A Strep, and periodontitis prevention using its XpressCF cell-free protein synthesis platform. Lead candidate VAX-24 is a 24-valent pneumococcal conjugate vaccine.